As the pharmaceutical industry faces increasing pressure to align with environmental, social and governance (ESG) initiatives, the demand for sustainable, cost-efficient and socially responsible practices has never been greater. In this webinar, industry leaders will share success stories, lessons learned and powerful insights on building critical ESG goals and programs that are driving societal change and lowering environmental impacts within the pharma supply chain.
Attendees will learn about ESG models and strategies that reduce waste, improve equity and drive process efficiency. The session will cover the growing consumer and investor demand for sustainable solutions and responsible ESG practices. Additionally, attendees will gain insights into the increasing adoption of transparent sustainability metrics and ESG reporting as standard practices, exemplified by annual sustainability assessments conducted through industry-leading platforms like EcoVadis.
The speakers will discuss the critical collaboration required between logistics, pharma companies and suppliers to meet ESG goals effectively. The webinar will highlight proven strategies for calculating resource consumption and developing reduction plans throughout the pharma logistics process. Additionally, it will emphasize the importance of tracking industry-wide efforts and comparing ESG benchmarks to establish baseline goals for sustainability.
The webinar will cover the role of advanced technologies, renewable energy sources and digital tools in supporting these ESG initiatives. The speakers will share real-life success stories, green pilot studies and lessons learned, providing actionable insights on resource optimization and cost-effective strategies. The session will also focus on investments in sustainable logistics initiatives, including energy-efficient cold-chain technologies and eco-friendly, reusable and recyclable packaging solutions.
Register for this webinar to discover innovative solutions, operational efficiencies and collaborative strategies that stakeholders across the pharma supply chain are implementing to reduce environmental footprint and waste, all while enhancing patient care.
Speakers
Deahne Baker, Director of Sustainability, Marken
Deahne Baker has been at Marken for almost a decade and is Director of Sustainability and Senior Legal Counsel. Her extensive experience in governmental regulations worldwide has been instrumental in establishing Marken’s reputation as a pharma logistics leader in ESG initiatives. Following a data-driven approach, Deahne defines clear goals across the company matrix to help resolve crucial ESG challenges and drive operational process efficiencies. Her unique expertise in the environmental impacts across the supply chain has been essential in the implementation and rapid growth of Marken’s sustainability initiatives, such as reaching benchmarks and achieving the ECOVADIS silver award status, placing Marken in the top 10 percent of sustainable organizations within the pharma logistics industry.
Sandra Voss, Senior Manager of Sustainability, Marken
Sandra Voss joined Marken in 2012 as a Project Manager of clinical trial logistics. Since this time, Sandra has managed multiple global clinical trial projects and collected leadership experience in director roles across direct-to-patient services, project management and personalized medicines. She supports additional functions within Marken, including sustainability, business development and quality assurance. Sandra has taken a critical role in meeting Marken’s ESG directives by developing standard operating procedures (SOPs), specialized training and certifying the Marken network, and managing other innovative sustainability projects.
Esmeralda Fecken, Lead Consultant, Business Consulting and Transformation, AllChiefs
Esmeralda Fecken is a Lead Consultant at AllChiefs with nearly a decade of experience in international people and organization consulting projects. With a background in tax law and a passion for translating complex matters into comprehensible content, she developed her interest for ESG. She is particularly passionate about the social (S) and governance (G) aspects of ESG and aspires to motivate companies to go beyond compliance and embrace the intrinsic benefits of responsible ESG actions.
André Annema, Co-Owner; Sustainability & Strategy; Partnerships, Acquisitions & Divestments, AllChiefs
André Annema is Co-Owner of AllChiefs and Co-Leader of the sustainable logistics practice since 2019. Prior to AllChiefs, he worked with McKinsey and Company in their global strategy and corporate finance practice. André has more than 25 years of experience advising clients across all major industry sectors on strategy, finance and transactions and partnerships, with a specific focus on sustainable logistics in the last five years. André is passionate about developing strategies based on thorough insights and understanding of the business drivers of emissions and working closely with clients to create the right conditions for the successful implementation of emission reduction roadmaps by engaging and activating all stakeholders.
Who Should Attend?
This webinar will appeal to senior professionals who are involved with:
- Pharmaceutical companies
- Biotechnology companies
- Central labs
- Contract manufacturing organizations (CMOs)
- Contract research organizations (CROs)
- Contract development and manufacturing organizations (CDMOs)
What You Will Learn
In this webinar, attendees will learn about:
- ESG models that reduce waste, improve equity and enhance process efficiency in pharma
- How transparent ESG metrics and reporting are becoming industry standards
- Collaboration strategies across the pharma supply chain to achieve ESG goals
- Advanced technologies, renewable energy and digital tools that are driving ESG initiatives with real-world success stories
- Sustainable logistics investments, such as energy-efficient cold-chain technologies and eco-friendly packaging solutions
Xtalks Partner
Marken
Marken, the clinical precision logistics and advanced therapy subsidiary of UPS Healthcare, includes MNX and Polar Speed. Offering a GMP-compliant depot network and logistics hubs for clinical drug product storage and distribution in 50 locations worldwide, Marken leads in Direct-to-Patient services, biological sample shipments, and kit production. Their 2,500+ staff manage 200,000 monthly shipments in 220+ countries and have arranged 17,500+ home healthcare visits. Services like advanced therapy supply chain, ancillary material sourcing, shipment lane verification, and GDP consultancy solidify Marken’s unique industry position.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account